Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The …
Medical - Healthcare Information Services
US, New York [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 45.90 | -25.62 | -47.35 | |
| Graham Fair Price | -10.78 | 11.00 | 12.33 | |
| PEG | 2019.86 | -0.11 | < 0.005 | |
| Price/Book | 2.70 | 3.71 | 3.61 | |
| Price/Cash Flow | -18.41 | -43.89 | -37.06 | |
| Prices/Earnings | -6.10 | -8.70 | -8.20 | |
| Price/Sales | 8.89 | 52.01 | 47.76 | |
| Price/FCF | -18.41 | -43.89 | -37.06 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -7.05 | 0.52 | 0.56 | |
| Operating Margin | -39.58 | -1.84 | -1.32 | |
| ROA | 5.03 | -0.07 | -0.08 | |
| ROE | -0.11 | -0.11 | 3.20 | |
| ROIC | -0.07 | -0.11 | -62.67 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.02 | 0.06 | -75.97 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.08 | -1.28 | 1479.71 | |
| EPS QOQ | -15.33 | -0.77 | 94.99 | |
| FCF QOQ | -1.63 | -0.09 | 94.25 | |
| Revenue QOQ | 0.21 | -0.51 | 141.40 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | -58.26 | < 0.005 | -100.00 | |
| Days Sales Outstanding (DSO) | 67.94 | 112.19 | 65.11 | |
| Inventory Turnover | -1.54 | 17708000.00 | 1146202351.14 | |
| Debt/Capitalization | 0.19 | 0.20 | 5.69 | |
| Quick Ratio | 5.03 | 4.48 | -11.03 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 7.84 | 7.11 | -9.31 | |
| Cash | 6.90 | 5.96 | -13.58 | |
| Capex | -0.07 | -0.06 | 17.14 | |
| Free Cash Flow | -0.76 | -0.60 | 21.34 | |
| Revenue | 0.59 | 0.51 | -14.46 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad